Reflexo Therapy for Gestational Diabetes Mellitus

Launched by KAFRELSHEIKH UNIVERSITY · May 8, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a treatment called Reflexo therapy on women with gestational diabetes mellitus (GDM), which is a type of diabetes that can occur during pregnancy. The goal of the study is to see if this therapy, applied to the sole of the foot, can help improve the health of expectant mothers and their babies. The trial is currently looking for female participants aged 20 to 35 years who are between 24 and 36 weeks pregnant and have a body mass index (BMI) of 30 or less.

To participate, women should be having a single pregnancy without any serious complications or stressful events. However, those with high-risk pregnancies, certain medical conditions, or who smoke are not eligible. If you join this trial, you can expect to receive Reflexo therapy and have regular check-ups during the study period to monitor your health and any effects of the treatment. This research is important for understanding new ways to manage gestational diabetes, which can impact both mothers and babies.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. They were maternally aged between 20 and 35 years.
• • 2. The gestational age ranged from between 24 and 36 weeks.
• • 3. Their BMI didn't exceed 30 kg/m2.
• • 4. A singleton live fetus and not under stressful event.
• • Exclusion Criteria
• • 1. They had high-risk pregnancies.
• • 2. Bad obstetric situations.
• • 3. Diseases that could interfere with participation.
• • 4. Smoking.
• • 5. Oral sedative administration.